Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
23:45:13 EDT Tue 21 Apr 2026
Enter Symbol
or Name
USA
CA



Q:CURX - CURANEX PHARMACEUTICALS INC - http://www.curaxispharma.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
CURX - Q0.10.4064·0.610.30.458-0.0188-3.923.571190.489  0.489  0.43219.1796  0.265116:00:01Apr 0815 min RT 2¢

Recent Trades - Last 10 of 119
Time ETExPriceChangeVolume
16:00:01Q0.458-0.01877
16:00:01Q0.458-0.0185
16:00:01Q0.458-0.01814
16:00:01Q0.458-0.01834
15:59:50Q0.4698-0.006223
15:59:41Q0.4698-0.006227
15:59:26Q0.4698-0.00621
15:59:25Q0.4698-0.006223
15:59:16Q0.458-0.0189
15:59:16Q0.4698-0.006228

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-04-08 07:47U:CURXNews ReleaseCuranex Highlights Five Additional Patient Cases Further Supporting the Potential of Its Lead Candidate in Cancer Cachexia, Advanced Cancer Supportive Care and Severe Systemic Decline
2026-04-06 09:17U:CURXNews ReleaseCuranex Highlights Patient Case Study Supporting Potential of Phyto-N in Cancer Cachexia and Advanced Cancer Supportive Care
2026-04-02 08:07U:CURXNews ReleaseCuranex Expands Its Drug Development Pipeline to Include Cancer Cachexia, Representing a Multi-Billion-Dollar Market Opportunity and Important Step In The Company's Evolution Into a Broader Therapeutics Development Company
2026-03-30 17:35U:CURXNews ReleaseCuranex Provides Business Update in Connection with 2025 Annual Report as Phyto-N Advances Toward Planned IND Submission
2026-03-18 08:00U:CURXNews ReleaseCuranex Achieves Key Preclinical Milestone with Favorable Toxicology Profile at Maximum Dose, Advancing Toward IND Submission
2026-03-12 09:30U:CURXNews ReleaseCuranex Expands Scientific Advisory Board With Two Distinguished Researchers
2026-03-11 08:00U:CURXNews ReleaseCuranex Appoints Two Veteran Industry Leaders to Scientific Advisory Board
2026-03-05 08:00U:CURXNews ReleaseCuranex Forms World Class Scientific Advisory Board
2026-02-25 08:00U:CURXNews ReleaseCuranex Provides Operational Update on Key Regulatory Milestones
2025-10-22 07:00U:CURXNews ReleaseCuranex Pharmaceuticals Inc. Engages Strategic Investor Relations to Enhance Investor Communications and Engagement
2025-09-12 14:46U:CURXNews ReleaseCuranex Pharmaceuticals Inc. Announces Exercise of the Over-Allotment Option by Underwriters
2025-08-27 17:00U:CURXNews ReleaseCuranex Pharmaceuticals Inc. Announces Closing of its Initial Public Offering
2025-08-26 07:30U:CURXNews ReleaseCuranex Pharmaceuticals Inc. Announces Pricing of its Initial Public Offering